nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC22A2—Cisplatin—urinary bladder cancer	0.166	0.643	CbGbCtD
Famotidine—SLC22A8—Methotrexate—urinary bladder cancer	0.0927	0.358	CbGbCtD
Famotidine—SLC22A8—urine—urinary bladder cancer	0.0213	0.189	CbGeAlD
Famotidine—CYP2C19—urine—urinary bladder cancer	0.0178	0.158	CbGeAlD
Famotidine—SLC47A1—prostate gland—urinary bladder cancer	0.00995	0.0884	CbGeAlD
Famotidine—SLC47A1—seminal vesicle—urinary bladder cancer	0.00841	0.0748	CbGeAlD
Famotidine—SLC22A2—renal system—urinary bladder cancer	0.00801	0.0712	CbGeAlD
Famotidine—SLC22A8—prostate gland—urinary bladder cancer	0.00763	0.0678	CbGeAlD
Famotidine—SLC47A1—renal system—urinary bladder cancer	0.00678	0.0603	CbGeAlD
Famotidine—SLC47A1—urethra—urinary bladder cancer	0.00666	0.0592	CbGeAlD
Famotidine—SLC47A1—female reproductive system—urinary bladder cancer	0.00543	0.0483	CbGeAlD
Famotidine—SLC22A8—renal system—urinary bladder cancer	0.0052	0.0462	CbGeAlD
Famotidine—SLC47A1—vagina—urinary bladder cancer	0.00491	0.0437	CbGeAlD
Famotidine—HRH2—lymph node—urinary bladder cancer	0.00411	0.0366	CbGeAlD
Famotidine—SLC47A1—lymph node—urinary bladder cancer	0.00318	0.0282	CbGeAlD
Famotidine—CYP2C19—vagina—urinary bladder cancer	0.00316	0.0281	CbGeAlD
Famotidine—Dry skin—Doxorubicin—urinary bladder cancer	0.000875	0.00139	CcSEcCtD
Famotidine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000873	0.00139	CcSEcCtD
Famotidine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000869	0.00138	CcSEcCtD
Famotidine—Anorexia—Etoposide—urinary bladder cancer	0.000862	0.00137	CcSEcCtD
Famotidine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000861	0.00137	CcSEcCtD
Famotidine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000859	0.00137	CcSEcCtD
Famotidine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000859	0.00137	CcSEcCtD
Famotidine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000858	0.00137	CcSEcCtD
Famotidine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000858	0.00136	CcSEcCtD
Famotidine—Bronchitis—Epirubicin—urinary bladder cancer	0.000857	0.00136	CcSEcCtD
Famotidine—Depression—Methotrexate—urinary bladder cancer	0.000847	0.00135	CcSEcCtD
Famotidine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000846	0.00135	CcSEcCtD
Famotidine—Pain—Cisplatin—urinary bladder cancer	0.000844	0.00134	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000842	0.00134	CcSEcCtD
Famotidine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000837	0.00133	CcSEcCtD
Famotidine—Neutropenia—Epirubicin—urinary bladder cancer	0.000833	0.00133	CcSEcCtD
Famotidine—Dysuria—Epirubicin—urinary bladder cancer	0.000833	0.00133	CcSEcCtD
Famotidine—Dizziness—Thiotepa—urinary bladder cancer	0.000832	0.00132	CcSEcCtD
Famotidine—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000828	0.00132	CcSEcCtD
Famotidine—Urticaria—Fluorouracil—urinary bladder cancer	0.000827	0.00132	CcSEcCtD
Famotidine—Influenza—Doxorubicin—urinary bladder cancer	0.000825	0.00131	CcSEcCtD
Famotidine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000823	0.00131	CcSEcCtD
Famotidine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000823	0.00131	CcSEcCtD
Famotidine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000814	0.00129	CcSEcCtD
Famotidine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000813	0.00129	CcSEcCtD
Famotidine—Paraesthesia—Etoposide—urinary bladder cancer	0.000812	0.00129	CcSEcCtD
Famotidine—Haematuria—Methotrexate—urinary bladder cancer	0.00081	0.00129	CcSEcCtD
Famotidine—Somnolence—Etoposide—urinary bladder cancer	0.000804	0.00128	CcSEcCtD
Famotidine—Vomiting—Thiotepa—urinary bladder cancer	0.0008	0.00127	CcSEcCtD
Famotidine—Rash—Thiotepa—urinary bladder cancer	0.000794	0.00126	CcSEcCtD
Famotidine—Bronchitis—Doxorubicin—urinary bladder cancer	0.000793	0.00126	CcSEcCtD
Famotidine—Dermatitis—Thiotepa—urinary bladder cancer	0.000793	0.00126	CcSEcCtD
Famotidine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000792	0.00126	CcSEcCtD
Famotidine—Headache—Thiotepa—urinary bladder cancer	0.000789	0.00125	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000788	0.00125	CcSEcCtD
Famotidine—Decreased appetite—Etoposide—urinary bladder cancer	0.000786	0.00125	CcSEcCtD
Famotidine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000783	0.00125	CcSEcCtD
Famotidine—Body temperature increased—Cisplatin—urinary bladder cancer	0.00078	0.00124	CcSEcCtD
Famotidine—Fatigue—Etoposide—urinary bladder cancer	0.00078	0.00124	CcSEcCtD
Famotidine—Jaundice—Epirubicin—urinary bladder cancer	0.000775	0.00123	CcSEcCtD
Famotidine—Pain—Etoposide—urinary bladder cancer	0.000773	0.00123	CcSEcCtD
Famotidine—Constipation—Etoposide—urinary bladder cancer	0.000773	0.00123	CcSEcCtD
Famotidine—Dysuria—Doxorubicin—urinary bladder cancer	0.000771	0.00123	CcSEcCtD
Famotidine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000771	0.00123	CcSEcCtD
Famotidine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000767	0.00122	CcSEcCtD
Famotidine—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000766	0.00122	CcSEcCtD
Famotidine—Hepatitis—Methotrexate—urinary bladder cancer	0.000762	0.00121	CcSEcCtD
Famotidine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000762	0.00121	CcSEcCtD
Famotidine—Asthenia—Gemcitabine—urinary bladder cancer	0.00076	0.00121	CcSEcCtD
Famotidine—Haematuria—Epirubicin—urinary bladder cancer	0.000758	0.00121	CcSEcCtD
Famotidine—Pharyngitis—Methotrexate—urinary bladder cancer	0.000757	0.0012	CcSEcCtD
Famotidine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000753	0.0012	CcSEcCtD
Famotidine—Pruritus—Gemcitabine—urinary bladder cancer	0.000749	0.00119	CcSEcCtD
Famotidine—Nausea—Thiotepa—urinary bladder cancer	0.000748	0.00119	CcSEcCtD
Famotidine—Sinusitis—Epirubicin—urinary bladder cancer	0.000746	0.00119	CcSEcCtD
Famotidine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000745	0.00119	CcSEcCtD
Famotidine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000742	0.00118	CcSEcCtD
Famotidine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000739	0.00118	CcSEcCtD
Famotidine—Pruritus—Fluorouracil—urinary bladder cancer	0.000737	0.00117	CcSEcCtD
Famotidine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000729	0.00116	CcSEcCtD
Famotidine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000727	0.00116	CcSEcCtD
Famotidine—Bradycardia—Epirubicin—urinary bladder cancer	0.000726	0.00116	CcSEcCtD
Famotidine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000724	0.00115	CcSEcCtD
Famotidine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000721	0.00115	CcSEcCtD
Famotidine—Urticaria—Etoposide—urinary bladder cancer	0.000718	0.00114	CcSEcCtD
Famotidine—Jaundice—Doxorubicin—urinary bladder cancer	0.000717	0.00114	CcSEcCtD
Famotidine—Abdominal pain—Etoposide—urinary bladder cancer	0.000715	0.00114	CcSEcCtD
Famotidine—Body temperature increased—Etoposide—urinary bladder cancer	0.000715	0.00114	CcSEcCtD
Famotidine—Hepatitis—Epirubicin—urinary bladder cancer	0.000713	0.00114	CcSEcCtD
Famotidine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000712	0.00113	CcSEcCtD
Famotidine—Tinnitus—Methotrexate—urinary bladder cancer	0.000711	0.00113	CcSEcCtD
Famotidine—Asthenia—Cisplatin—urinary bladder cancer	0.000708	0.00113	CcSEcCtD
Famotidine—Pharyngitis—Epirubicin—urinary bladder cancer	0.000708	0.00113	CcSEcCtD
Famotidine—Haematuria—Doxorubicin—urinary bladder cancer	0.000701	0.00112	CcSEcCtD
Famotidine—Sinusitis—Doxorubicin—urinary bladder cancer	0.00069	0.0011	CcSEcCtD
Famotidine—Dizziness—Fluorouracil—urinary bladder cancer	0.000688	0.0011	CcSEcCtD
Famotidine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000686	0.00109	CcSEcCtD
Famotidine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000675	0.00107	CcSEcCtD
Famotidine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000675	0.00107	CcSEcCtD
Famotidine—Alopecia—Methotrexate—urinary bladder cancer	0.000674	0.00107	CcSEcCtD
Famotidine—Vomiting—Gemcitabine—urinary bladder cancer	0.000673	0.00107	CcSEcCtD
Famotidine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000672	0.00107	CcSEcCtD
Famotidine—Mental disorder—Methotrexate—urinary bladder cancer	0.000668	0.00106	CcSEcCtD
Famotidine—Rash—Gemcitabine—urinary bladder cancer	0.000668	0.00106	CcSEcCtD
Famotidine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000667	0.00106	CcSEcCtD
Famotidine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000666	0.00106	CcSEcCtD
Famotidine—Tinnitus—Epirubicin—urinary bladder cancer	0.000665	0.00106	CcSEcCtD
Famotidine—Headache—Gemcitabine—urinary bladder cancer	0.000663	0.00106	CcSEcCtD
Famotidine—Flushing—Epirubicin—urinary bladder cancer	0.000662	0.00105	CcSEcCtD
Famotidine—Vomiting—Fluorouracil—urinary bladder cancer	0.000662	0.00105	CcSEcCtD
Famotidine—Hepatitis—Doxorubicin—urinary bladder cancer	0.00066	0.00105	CcSEcCtD
Famotidine—Rash—Fluorouracil—urinary bladder cancer	0.000656	0.00104	CcSEcCtD
Famotidine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000656	0.00104	CcSEcCtD
Famotidine—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000655	0.00104	CcSEcCtD
Famotidine—Headache—Fluorouracil—urinary bladder cancer	0.000652	0.00104	CcSEcCtD
Famotidine—Dysgeusia—Methotrexate—urinary bladder cancer	0.00065	0.00103	CcSEcCtD
Famotidine—Asthenia—Etoposide—urinary bladder cancer	0.000649	0.00103	CcSEcCtD
Famotidine—Back pain—Methotrexate—urinary bladder cancer	0.000642	0.00102	CcSEcCtD
Famotidine—Pruritus—Etoposide—urinary bladder cancer	0.00064	0.00102	CcSEcCtD
Famotidine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000637	0.00101	CcSEcCtD
Famotidine—Alopecia—Epirubicin—urinary bladder cancer	0.00063	0.001	CcSEcCtD
Famotidine—Nausea—Gemcitabine—urinary bladder cancer	0.000629	0.001	CcSEcCtD
Famotidine—Vomiting—Cisplatin—urinary bladder cancer	0.000628	0.000998	CcSEcCtD
Famotidine—Mental disorder—Epirubicin—urinary bladder cancer	0.000625	0.000994	CcSEcCtD
Famotidine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000624	0.000993	CcSEcCtD
Famotidine—Rash—Cisplatin—urinary bladder cancer	0.000622	0.00099	CcSEcCtD
Famotidine—Dermatitis—Cisplatin—urinary bladder cancer	0.000622	0.000989	CcSEcCtD
Famotidine—Diarrhoea—Etoposide—urinary bladder cancer	0.000619	0.000984	CcSEcCtD
Famotidine—Nausea—Fluorouracil—urinary bladder cancer	0.000618	0.000984	CcSEcCtD
Famotidine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000615	0.000979	CcSEcCtD
Famotidine—Anaemia—Methotrexate—urinary bladder cancer	0.000613	0.000976	CcSEcCtD
Famotidine—Flushing—Doxorubicin—urinary bladder cancer	0.000613	0.000975	CcSEcCtD
Famotidine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000608	0.000968	CcSEcCtD
Famotidine—Back pain—Epirubicin—urinary bladder cancer	0.000601	0.000956	CcSEcCtD
Famotidine—Dizziness—Etoposide—urinary bladder cancer	0.000598	0.000951	CcSEcCtD
Famotidine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000597	0.00095	CcSEcCtD
Famotidine—Leukopenia—Methotrexate—urinary bladder cancer	0.000594	0.000945	CcSEcCtD
Famotidine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00059	0.000938	CcSEcCtD
Famotidine—Nausea—Cisplatin—urinary bladder cancer	0.000586	0.000933	CcSEcCtD
Famotidine—Alopecia—Doxorubicin—urinary bladder cancer	0.000583	0.000928	CcSEcCtD
Famotidine—Cough—Methotrexate—urinary bladder cancer	0.000579	0.000921	CcSEcCtD
Famotidine—Mental disorder—Doxorubicin—urinary bladder cancer	0.000578	0.00092	CcSEcCtD
Famotidine—Convulsion—Methotrexate—urinary bladder cancer	0.000575	0.000915	CcSEcCtD
Famotidine—Vomiting—Etoposide—urinary bladder cancer	0.000575	0.000915	CcSEcCtD
Famotidine—Anaemia—Epirubicin—urinary bladder cancer	0.000574	0.000913	CcSEcCtD
Famotidine—Agitation—Epirubicin—urinary bladder cancer	0.000571	0.000908	CcSEcCtD
Famotidine—Rash—Etoposide—urinary bladder cancer	0.00057	0.000907	CcSEcCtD
Famotidine—Dermatitis—Etoposide—urinary bladder cancer	0.00057	0.000906	CcSEcCtD
Famotidine—Headache—Etoposide—urinary bladder cancer	0.000566	0.000901	CcSEcCtD
Famotidine—Chest pain—Methotrexate—urinary bladder cancer	0.000565	0.000899	CcSEcCtD
Famotidine—Myalgia—Methotrexate—urinary bladder cancer	0.000565	0.000899	CcSEcCtD
Famotidine—Arthralgia—Methotrexate—urinary bladder cancer	0.000565	0.000899	CcSEcCtD
Famotidine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000563	0.000895	CcSEcCtD
Famotidine—Syncope—Epirubicin—urinary bladder cancer	0.000557	0.000886	CcSEcCtD
Famotidine—Leukopenia—Epirubicin—urinary bladder cancer	0.000556	0.000884	CcSEcCtD
Famotidine—Back pain—Doxorubicin—urinary bladder cancer	0.000556	0.000884	CcSEcCtD
Famotidine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000552	0.000879	CcSEcCtD
Famotidine—Palpitations—Epirubicin—urinary bladder cancer	0.000549	0.000873	CcSEcCtD
Famotidine—Confusional state—Methotrexate—urinary bladder cancer	0.000546	0.000869	CcSEcCtD
Famotidine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000546	0.000868	CcSEcCtD
Famotidine—Cough—Epirubicin—urinary bladder cancer	0.000542	0.000862	CcSEcCtD
Famotidine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000542	0.000862	CcSEcCtD
Famotidine—Convulsion—Epirubicin—urinary bladder cancer	0.000538	0.000856	CcSEcCtD
Famotidine—Infection—Methotrexate—urinary bladder cancer	0.000538	0.000856	CcSEcCtD
Famotidine—Nausea—Etoposide—urinary bladder cancer	0.000537	0.000854	CcSEcCtD
Famotidine—Anaemia—Doxorubicin—urinary bladder cancer	0.000531	0.000845	CcSEcCtD
Famotidine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00053	0.000844	CcSEcCtD
Famotidine—Myalgia—Epirubicin—urinary bladder cancer	0.000529	0.000841	CcSEcCtD
Famotidine—Arthralgia—Epirubicin—urinary bladder cancer	0.000529	0.000841	CcSEcCtD
Famotidine—Chest pain—Epirubicin—urinary bladder cancer	0.000529	0.000841	CcSEcCtD
Famotidine—Agitation—Doxorubicin—urinary bladder cancer	0.000528	0.00084	CcSEcCtD
Famotidine—Anxiety—Epirubicin—urinary bladder cancer	0.000527	0.000838	CcSEcCtD
Famotidine—Dry mouth—Epirubicin—urinary bladder cancer	0.000517	0.000823	CcSEcCtD
Famotidine—Anorexia—Methotrexate—urinary bladder cancer	0.000516	0.000821	CcSEcCtD
Famotidine—Syncope—Doxorubicin—urinary bladder cancer	0.000515	0.00082	CcSEcCtD
Famotidine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000514	0.000818	CcSEcCtD
Famotidine—Confusional state—Epirubicin—urinary bladder cancer	0.000511	0.000813	CcSEcCtD
Famotidine—Palpitations—Doxorubicin—urinary bladder cancer	0.000508	0.000808	CcSEcCtD
Famotidine—Oedema—Epirubicin—urinary bladder cancer	0.000507	0.000806	CcSEcCtD
Famotidine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000507	0.000806	CcSEcCtD
Famotidine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000505	0.000804	CcSEcCtD
Famotidine—Infection—Epirubicin—urinary bladder cancer	0.000504	0.000801	CcSEcCtD
Famotidine—Cough—Doxorubicin—urinary bladder cancer	0.000501	0.000798	CcSEcCtD
Famotidine—Shock—Epirubicin—urinary bladder cancer	0.000499	0.000793	CcSEcCtD
Famotidine—Convulsion—Doxorubicin—urinary bladder cancer	0.000498	0.000792	CcSEcCtD
Famotidine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000496	0.00079	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000493	0.000785	CcSEcCtD
Famotidine—Insomnia—Methotrexate—urinary bladder cancer	0.00049	0.000779	CcSEcCtD
Famotidine—Chest pain—Doxorubicin—urinary bladder cancer	0.000489	0.000778	CcSEcCtD
Famotidine—Myalgia—Doxorubicin—urinary bladder cancer	0.000489	0.000778	CcSEcCtD
Famotidine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000489	0.000778	CcSEcCtD
Famotidine—Anxiety—Doxorubicin—urinary bladder cancer	0.000488	0.000776	CcSEcCtD
Famotidine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000486	0.000774	CcSEcCtD
Famotidine—Anorexia—Epirubicin—urinary bladder cancer	0.000483	0.000769	CcSEcCtD
Famotidine—Somnolence—Methotrexate—urinary bladder cancer	0.000481	0.000766	CcSEcCtD
Famotidine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000478	0.000761	CcSEcCtD
Famotidine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000477	0.000758	CcSEcCtD
Famotidine—Confusional state—Doxorubicin—urinary bladder cancer	0.000473	0.000752	CcSEcCtD
Famotidine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000471	0.000749	CcSEcCtD
Famotidine—Oedema—Doxorubicin—urinary bladder cancer	0.000469	0.000746	CcSEcCtD
Famotidine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000469	0.000746	CcSEcCtD
Famotidine—Fatigue—Methotrexate—urinary bladder cancer	0.000467	0.000743	CcSEcCtD
Famotidine—Infection—Doxorubicin—urinary bladder cancer	0.000466	0.000741	CcSEcCtD
Famotidine—Pain—Methotrexate—urinary bladder cancer	0.000463	0.000737	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000462	0.000735	CcSEcCtD
Famotidine—Shock—Doxorubicin—urinary bladder cancer	0.000461	0.000734	CcSEcCtD
Famotidine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000459	0.000731	CcSEcCtD
Famotidine—Insomnia—Epirubicin—urinary bladder cancer	0.000458	0.000729	CcSEcCtD
Famotidine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000455	0.000724	CcSEcCtD
Famotidine—Somnolence—Epirubicin—urinary bladder cancer	0.000451	0.000717	CcSEcCtD
Famotidine—Anorexia—Doxorubicin—urinary bladder cancer	0.000447	0.000711	CcSEcCtD
Famotidine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000446	0.00071	CcSEcCtD
Famotidine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000446	0.00071	CcSEcCtD
Famotidine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000443	0.000705	CcSEcCtD
Famotidine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000441	0.000701	CcSEcCtD
Famotidine—Fatigue—Epirubicin—urinary bladder cancer	0.000437	0.000695	CcSEcCtD
Famotidine—Pain—Epirubicin—urinary bladder cancer	0.000433	0.00069	CcSEcCtD
Famotidine—Constipation—Epirubicin—urinary bladder cancer	0.000433	0.00069	CcSEcCtD
Famotidine—Urticaria—Methotrexate—urinary bladder cancer	0.00043	0.000685	CcSEcCtD
Famotidine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000428	0.000681	CcSEcCtD
Famotidine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000428	0.000681	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000427	0.00068	CcSEcCtD
Famotidine—Insomnia—Doxorubicin—urinary bladder cancer	0.000424	0.000675	CcSEcCtD
Famotidine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000421	0.00067	CcSEcCtD
Famotidine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000418	0.000665	CcSEcCtD
Famotidine—Somnolence—Doxorubicin—urinary bladder cancer	0.000417	0.000663	CcSEcCtD
Famotidine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000414	0.000659	CcSEcCtD
Famotidine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000413	0.000657	CcSEcCtD
Famotidine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000408	0.000649	CcSEcCtD
Famotidine—Fatigue—Doxorubicin—urinary bladder cancer	0.000404	0.000643	CcSEcCtD
Famotidine—Urticaria—Epirubicin—urinary bladder cancer	0.000403	0.000641	CcSEcCtD
Famotidine—Pain—Doxorubicin—urinary bladder cancer	0.000401	0.000638	CcSEcCtD
Famotidine—Constipation—Doxorubicin—urinary bladder cancer	0.000401	0.000638	CcSEcCtD
Famotidine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000401	0.000637	CcSEcCtD
Famotidine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000401	0.000637	CcSEcCtD
Famotidine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000399	0.000635	CcSEcCtD
Famotidine—Asthenia—Methotrexate—urinary bladder cancer	0.000389	0.000618	CcSEcCtD
Famotidine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000386	0.000615	CcSEcCtD
Famotidine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000383	0.00061	CcSEcCtD
Famotidine—Pruritus—Methotrexate—urinary bladder cancer	0.000383	0.00061	CcSEcCtD
Famotidine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000373	0.000594	CcSEcCtD
Famotidine—Urticaria—Doxorubicin—urinary bladder cancer	0.000373	0.000593	CcSEcCtD
Famotidine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000371	0.00059	CcSEcCtD
Famotidine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000371	0.00059	CcSEcCtD
Famotidine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000371	0.00059	CcSEcCtD
Famotidine—Asthenia—Epirubicin—urinary bladder cancer	0.000364	0.000579	CcSEcCtD
Famotidine—Pruritus—Epirubicin—urinary bladder cancer	0.000359	0.000571	CcSEcCtD
Famotidine—Dizziness—Methotrexate—urinary bladder cancer	0.000358	0.00057	CcSEcCtD
Famotidine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000347	0.000552	CcSEcCtD
Famotidine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000346	0.00055	CcSEcCtD
Famotidine—Vomiting—Methotrexate—urinary bladder cancer	0.000344	0.000548	CcSEcCtD
Famotidine—Rash—Methotrexate—urinary bladder cancer	0.000341	0.000543	CcSEcCtD
Famotidine—Dermatitis—Methotrexate—urinary bladder cancer	0.000341	0.000543	CcSEcCtD
Famotidine—Headache—Methotrexate—urinary bladder cancer	0.000339	0.00054	CcSEcCtD
Famotidine—Asthenia—Doxorubicin—urinary bladder cancer	0.000336	0.000535	CcSEcCtD
Famotidine—Dizziness—Epirubicin—urinary bladder cancer	0.000335	0.000533	CcSEcCtD
Famotidine—Pruritus—Doxorubicin—urinary bladder cancer	0.000332	0.000528	CcSEcCtD
Famotidine—Vomiting—Epirubicin—urinary bladder cancer	0.000322	0.000513	CcSEcCtD
Famotidine—Nausea—Methotrexate—urinary bladder cancer	0.000322	0.000512	CcSEcCtD
Famotidine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000321	0.000511	CcSEcCtD
Famotidine—Rash—Epirubicin—urinary bladder cancer	0.00032	0.000508	CcSEcCtD
Famotidine—Dermatitis—Epirubicin—urinary bladder cancer	0.000319	0.000508	CcSEcCtD
Famotidine—Headache—Epirubicin—urinary bladder cancer	0.000318	0.000505	CcSEcCtD
Famotidine—Dizziness—Doxorubicin—urinary bladder cancer	0.00031	0.000493	CcSEcCtD
Famotidine—Nausea—Epirubicin—urinary bladder cancer	0.000301	0.000479	CcSEcCtD
Famotidine—Vomiting—Doxorubicin—urinary bladder cancer	0.000298	0.000474	CcSEcCtD
Famotidine—Rash—Doxorubicin—urinary bladder cancer	0.000296	0.00047	CcSEcCtD
Famotidine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000295	0.00047	CcSEcCtD
Famotidine—Headache—Doxorubicin—urinary bladder cancer	0.000294	0.000467	CcSEcCtD
Famotidine—Nausea—Doxorubicin—urinary bladder cancer	0.000279	0.000443	CcSEcCtD
